Session Details

F089 Hand and Foot Psoriasis, Dermatitis, and Other Inflammatory Dermatoses

Sun, Mar 10, 3:30 PM - 5:30 PM
Room 30DE
2 CME Available Forum
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

Common inflammatory dermatoses such as psoriasis, atopic dermatitis and contact dermatitis often involve hands and feet. The morphology of many of these dermatoses is different on palms and soles, making the diagnosis more challenging. In addition, inflammatory conditions involving palms and soles often do not respond as well to topical and systemic treatments. This session will review the different clinical presentations of common hand and feet dermatoses and the role of patch testing. The focus will be on the management of hand and foot psoriasis, dermatitis and palmo-plantar pustulosis. Recent data on the efficacy of biological agents and oral systemic agents and will be reviewed and discussed.

LEARNING OBJECTIVES

1.

Identify and diagnose common inflammatory hand and foot inflammatory dermatoses including psoriasis, irritant and allergic contact dermatitis and palmoplantar pustulosis

2.

Identify which patients with hand and foot inflammatory dermatoses should be patch tested and use the proper allergens and series

3.

Use evidence-based data to select the best treatment options (including topical, phototherapy and systemic therapy) for hand and foot psoriasis, dermatitis and palmoplantar pustulosis

SCHEDULE

10:30 PM

1) Introduction and differential diagnosis

Robert Bissonnette, MD, MSc, FAAD

10:55 PM

2) Role of patch testing in patients with inflammatory hand and foot dermatoses

David Eric Cohen, MD, FAAD

11:20 PM

3) Management of hand and foot dermatitis

Emma Guttman, MD, PhD, FAAD

11:45 PM

4) Management of hand and foot psoriasis

Bruce Elliot Strober, MD, PhD, FAAD

12:10 AM

Questions

SPEAKERS

Robert Bissonnette, MD, MSc, FAAD

Robert Bissonnette, MD, MSc, FAAD

David Eric Cohen, MD, FAAD

David Eric Cohen, MD, FAAD

Emma Guttman, MD, PhD, FAAD

Emma Guttman, MD, PhD, FAAD

Bruce Elliot Strober, MD, PhD, FAAD

Bruce Elliot Strober, MD, PhD, FAAD

HANDOUTS

Login to view handouts

SPEAKER DISCLOSURES

Robert Bissonnette, MD, MSc, FAAD

AbbVie – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Aclaris Therapeutics Inc. – Investigator(Grants/Research Funding); Alumis – Investigator(Grants/Research Funding); Amgen – Consultant(Honoraria); Apogee Therapeutics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Arcutis, Inc. – Investigator(Grants/Research Funding); Arena Pharmaceuticals – Investigator(Grants/Research Funding); Areteia Therapeutics – Consultant (1099 relationship)(Honoraria); Artax Biopharma – Investigator(Grants/Research Funding); BioMimetix JV, LLC – Investigator(Grants/Research Funding); BMS – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Brickell Biotech, Inc – Investigator(Grants/Research Funding); Cara Therapeutics – Investigator(Grants/Research Funding); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Dermavant Sciences – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria); Escient – Investigator(Grants/Research Funding); Horizon Pharma, Inc. – Investigator(Grants/Research Funding); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Inmagene Biopharmaceuticals – Consultant(Honoraria), Investigator(Grants/Research Funding); Innovaderm Research Inc. – Stockholder(Stock); Janssen Scientific Affairs, LLC – Consultant(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Merck – Investigator(Grants/Research Funding); Nektar Therapeutics – Investigator(Grants/Research Funding); Nimbus Therapeutics – Investigator(Grants/Research Funding); opsidio – Investigator(Grants/Research Funding); Pelage Pharmaceuticals – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Q32 Bio Inc. – Investigator(Grants/Research Funding); RAPT Therapeutics – Consultant(Honoraria); Sanofi Aventis – Consultant(Honoraria); Sanofi Genzyme – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Sitryx – Consultant (1099 relationship)(Honoraria); TARGET Pharma – Consultant(Honoraria), Investigator(Grants/Research Funding); UCB – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Ventyx Biosciences – Investigator(Grants/Research Funding); Xencor – Investigator(Grants/Research Funding); Zai Lab – Investigator(Grants/Research Funding);

David Eric Cohen, MD, FAAD

Cosmetic Ingredient Review – Advisory Board(Honoraria), Consultant (1099 relationship)(Fees); Dermira – Board of Directors(Stock); Evommune, Inc. – Board of Directors(Fees), Board of Directors(Stock Options); Facilitation of International Dermatology Education – Consultant(Honoraria); Ferndale Laboratories, Inc. – Consultant(Honoraria); Kadmon Corporation, LLC – Board of Directors(Fees), Board of Directors(Stock Options); LEO Laboratories Ltd (LEO Pharma) – Consultant(Honoraria); Medimetriks Pharmaceuticals, Inc. – Consultant(Honoraria); Novartis – Consultant(Honoraria); SFJ Pharmaceuticals – Consultant(Honoraria); Timber Pharmaceuticals – Board of Directors(Fees), Board of Directors(Stock Options); UCB – Consultant(Honoraria);

Emma Guttman, MD, PhD, FAAD

AbbVie – Consultant(Fees), Consultant(Honoraria); Almirall – Consultant(Fees), Consultant(Honoraria); Amgen – Consultant(Fees), Consultant(Honoraria), Investigator(Grants/Research Funding); AnaptysBio – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Apogee Therapeutics – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Apollo Therapeutics Ltd – Investigator(Grants/Research Funding); Artax Biopharma – Consultant (1099 relationship)(Fees), Consultant (1099 relationship)(Honoraria); ASLAN – Investigator(Grants/Research Funding); AstraZeneca – Consultant (1099 relationship)(Fees), Consultant (1099 relationship)(Honoraria); Boehringer Ingelheim – Consultant(Fees), Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Advisory Board(Fees), Advisory Board(Honoraria), Consultant(Fees), Consultant(Honoraria); Cara Therapeutics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Centrexion Therapeutics Corporation – Consultant (1099 relationship)(Fees); Concert Pharmaceuticals – Investigator(Grants/Research Funding); Connect Biopharma LLC – Consultant(Fees), Consultant(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Consultant(Honoraria), Consultant (1099 relationship)(Fees); Enveda Biosciences – Consultant (1099 relationship)(Fees); Escient Pharmaceuticals, Inc – Consultant (1099 relationship)(Fees); Fairmount Funds Management LLC – Consultant (1099 relationship)(Fees); Forest Laboratories – Consultant (1099 relationship)(Fees); Galderma Research & Development, LLC – Advisory Board(Honoraria), Consultant(Honoraria), Consultant (1099 relationship)(Fees); Gate Bioscience – Consultant(Honoraria), Consultant (1099 relationship)(Fees); GlaxoSmithKline – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); GlaxoSmithKline Immunology – Consultant (1099 relationship)(Fees); Google Ventures – Consultant (1099 relationship)(Fees); Horizon Therapeutics USA, Inc – Consultant (1099 relationship)(Fees); Incyte Corporation – Advisory Board(Honoraria), Consultant(Honoraria), Consultant (1099 relationship)(Fees); janssen – Consultant(Honoraria); Janssen Biotech – Consultant (1099 relationship)(Fees); Janssen Pharmaceuticals, Inc – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Japan Tobacco Inc. – Consultant (1099 relationship)(Fees); Jasper Therapeutics – Consultant (1099 relationship)(Fees); JT Central Pharmaceutical Research Institute – Consultant (1099 relationship)(Fees); Kyowa Hakko Kirin Pharma, Inc. – Advisory Board(Honoraria), Consultant(Honoraria), Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Leo Pharma Inc – Advisory Board(Honoraria), Consultant(Fees), Consultant(Honoraria), Investigator(Grants/Research Funding); Merck – Consultant(Fees), Consultant(Honoraria); Nektar Therapeutics – Consultant (1099 relationship)(Fees); Novartis Pharmaceuticals Corporation – Consultant (1099 relationship)(Fees); NUMAB Therapeutics AG – Consultant (1099 relationship)(Fees); OrbiMed Advisors LLC – Consultant (1099 relationship)(Fees); Otsuka Pharmaceutical Co., Ltd. – Consultant (1099 relationship)(Fees); Pfizer Inc. – Advisory Board(Honoraria), Consultant(Fees), Consultant(Honoraria), Investigator(Grants/Research Funding); Pharmaxis Ltd – Consultant (1099 relationship)(Fees); Pioneering Medicine VII, Inc – Consultant (1099 relationship)(Fees); Pioneering Medicines – Consultant (1099 relationship)(Fees); Proteologix US Inc – Consultant (1099 relationship)(Fees); RAPT Therapeutics – Consultant (1099 relationship)(Fees), Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding), Stockholder(Stock Options); Regeneron – Advisory Board(Honoraria), Consultant(Fees), Consultant(Honoraria); Regeneron Pharmaceuticals, Inc. – Investigator(Grants/Research Funding); RibonTherapeutics, Inc., – Consultant (1099 relationship)(Fees); Sanofi – Advisory Board(Honoraria), Consultant(Fees), Consultant(Honoraria), Investigator(Grants/Research Funding); SATO Pharmaceutical Co., Ltd – Consultant(Fees), Consultant(Honoraria); Schro¨dinger, Inc – Consultant (1099 relationship)(Fees); Sun Pharma Advanced Research Company (SPARC) – Consultant (1099 relationship)(Fees); Teva – Consultant (1099 relationship)(Fees); Teva Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Fees); UCB – Consultant(Fees), Consultant(Honoraria), Investigator(Grants/Research Funding);

Bruce Elliot Strober, MD, PhD, FAAD

AbbVie – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Alumis – Consultant(Fees); Amgen – Consultant (1099 relationship)(Fees); Arcutis, Inc. – Consultant(Fees), Speaker(Honoraria); Boehringer Ingelheim – Consultant(Honoraria); Bristol Myers Squibb – Speaker(Honoraria); Bristol-Myers Squibb – Advisory Board(Honoraria), Consultant(Fees); Connect Biopharma LLC – Stockholder(Other Financial Benefit); CoreEvitas, LLC – Advisory Board(Honoraria), Investigator(Fees); Dermavant Sciences, Inc. – Consultant(Fees), Speaker(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); Janssen Biotech – Speaker(Honoraria); Janssen-Ortho Inc. – Advisory Board(Honoraria), Consultant(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria), Consultant(Honoraria); Meiji Seika Pharma Co., Ltd – Consultant(Fees); Mindera – Stockholder(Other Financial Benefit); Novartis Pharmaceuticals Corp. – Advisory Board(Honoraria), Consultant(Honoraria); Oruka Therapeutics – Advisory Board(Honoraria); Pfizer Inc. – Consultant(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Consultant(Honoraria), Speaker(Honoraria); UCB – Advisory Board(Honoraria), Consultant(Fees), Speaker(Honoraria); Union Therapeutics – Consultant(Fees);